This is a timely compilation of new concepts in the molecular pathogenesis and molecular therapy of Acute Myelogenous Leukemia (AML).
The focus is on selected critical molecular determinants of AML pathogenesis and pathophysiology and the exploitation of these factors by diverse therapeutic agents and modalities..
This is a timely compilation of new concepts in the molecular pathogenesis and molecular therapy of Acute Myelogenous Leukemia (AML)